相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors
Tamera D. Hughes et al.
MOLECULES (2022)
Designing a natural inhibitor against human kynurenine aminotransferase type II and a comparison with PF-04859989: a computational effort against schizophrenia
Akbar Noorbakhsh et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Gender-specific elevation of plasma anthranilic acid in schizophrenia: Protection against glutamatergic hypofunction?
Johann Steiner et al.
SCHIZOPHRENIA RESEARCH (2022)
The Kynurenine Pathway in Traumatic Brain Injury: Implications for Psychiatric Outcomes
Timothy B. Meier et al.
BIOLOGICAL PSYCHIATRY (2022)
The pros and cons of motor, memory, and emotion-related behavioral tests in the mouse traumatic brain injury model
Ruoyu Zhang et al.
NEUROLOGICAL RESEARCH (2022)
Advances toward precision medicine for bipolar disorder: mechanisms & molecules
Stephen J. Haggarty et al.
MOLECULAR PSYCHIATRY (2021)
Urinary kynurenine as a biomarker for Parkinson's disease
Jia-he Bai et al.
NEUROLOGICAL SCIENCES (2021)
The role of the microbiota-gut-brain axis in neuropsychiatric disorders
Jaqueline S. Generoso et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2021)
Advantages of brain penetrating inhibitors of kynurenine-3-monooxygenase for treatment of neurodegenerative diseases
Shaowei Zhang et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)
Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT6 receptor antagonist with therapeutic interest in Alzheimer's disease
Francois-Xavier Toublet et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Natural Molecules and Neuroprotection: Kynurenic Acid, Pantethine and α-Lipoic Acid
Fanni Toth et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis
Bing Cao et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)
Immunosuppressive Amino-Acid Catabolizing Enzymes in Multiple Sclerosis
Jorge Correale
FRONTIERS IN IMMUNOLOGY (2021)
Microglia-derived interleukin-10 accelerates post-intracerebral hemorrhage hematoma clearance by regulating CD36
Qian Li et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin
Tomasz Pawlowski et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2021)
Increased serum QUIN/KYNA is a reliable biomarker of post-stroke cognitive decline
Adrien Cogo et al.
MOLECULAR NEURODEGENERATION (2021)
Sex-specific alterations in NAD plus metabolism in 3xTg Alzheimer's disease mouse brain assessed by quantitative targeted LC-MS
Vera van Der Velpen et al.
JOURNAL OF NEUROCHEMISTRY (2021)
Traumatic Brain Injury: Ultrastructural Features in Neuronal Ferroptosis, Glial Cell Activation and Polarization, and Blood-Brain Barrier Breakdown
Delong Qin et al.
CELLS (2021)
Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
Daniel Pukoli et al.
FRONTIERS IN NEUROSCIENCE (2021)
Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain
Yuanyuan Deng et al.
GUT MICROBES (2021)
Physiopathology of ischemic stroke and its modulation using memantine: evidence from preclinical stroke
Hilda Martinez-Coria et al.
NEURAL REGENERATION RESEARCH (2021)
Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia
Jochen Kindler et al.
MOLECULAR PSYCHIATRY (2020)
The kynurenine pathway: a finger in every pie
Jonathan Savitz
MOLECULAR PSYCHIATRY (2020)
Modification of kynurenine pathway via inhibition of kynurenine hydroxylase attenuates surgical brain injury complications in a male rat model
George Zakhary et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2020)
Plasma Indoleamine-2,3-Dioxygenase (IDO) is Increased in Drug-Naive Major Depressed Patients and Treatment with Sertraline and Ketoprofen Normalizes IDO in Association with Pro-Inflammatory and Immune-Regulatory Cytokines
Hussein Kadhem Al-Hakeim et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2020)
Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals
Luca Steardo et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2020)
Increased plasma melatonin in presymptomatic Huntington disease sheep (Ovis aries): Compensatory neuroprotection in a neurodegenerative disease?
A. Jennifer Morton et al.
JOURNAL OF PINEAL RESEARCH (2020)
Memory and cerebrovascular deficits recovered following angiotensin IV intervention in a mouse model of Alzheimer's disease
Jessika Royea et al.
NEUROBIOLOGY OF DISEASE (2020)
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation
Giada Mondanelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Serum Metabolic Profiles of the Tryptophan-Kynurenine Pathway in the high risk subjects of major depressive disorder
Masashi Sakurai et al.
SCIENTIFIC REPORTS (2020)
Prospective study of the effects of sport-related concussion on serum kynurenine pathway metabolites
Timothy B. Meier et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis
Cecilia Rajda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Potential therapeutic targets for intracerebral hemorrhage-associated inflammation: An update
Honglei Ren et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2020)
Neuroinflammation in Bipolar Depression
Francesco Benedetti et al.
FRONTIERS IN PSYCHIATRY (2020)
Tryptophan metabolites modify brain Aβ peptide degradation: A role in Alzheimer's disease?
Michel Maitre et al.
PROGRESS IN NEUROBIOLOGY (2020)
Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task
David Phenis et al.
PSYCHOPHARMACOLOGY (2020)
Possibility of Amino Acid Treatment to Prevent the Psychiatric Disorders via Modulation of the Production of Tryptophan Metabolite Kynurenic Acid
Tsutomu Fukuwatari
NUTRIENTS (2020)
Tryptophan Metabolism, Inflammation, and Oxidative Stress in Patients with Neurovascular Disease
Martin Hajsl et al.
METABOLITES (2020)
Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis
Henrique Lemos et al.
FRONTIERS IN IMMUNOLOGY (2020)
Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
Tamas Biernacki et al.
CELLS (2020)
Melatonin-A Potent Therapeutic for Stroke and Stroke-Related Dementia
Nadia Sadanandan et al.
ANTIOXIDANTS (2020)
Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression
Gayathri Sundaram et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease
Patrick L. Heilman et al.
MOVEMENT DISORDERS (2020)
The Trace Kynurenine, Cinnabarinic Acid, Displays Potent Antipsychotic-Like Activity in Mice and Its Levels Are Reduced in the Prefrontal Cortex of Individuals Affected by Schizophrenia
Martina Ulivieri et al.
SCHIZOPHRENIA BULLETIN (2020)
Progress in the development of kynurenine and quinoline-3-carboxamide-derived drugs
Fanni Boros et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine
Luis Felipe Campesato et al.
NATURE COMMUNICATIONS (2020)
Treatment of intracerebral hemorrhage: Current approaches and future directions
Wenbo Zhao et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Exposure to elevated embryonic kynurenine in rats: Sex-dependent learning and memory impairments in adult offspring
Silas A. Buck et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2020)
Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses
Lauren M. F. Merlo et al.
FRONTIERS IN IMMUNOLOGY (2020)
Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway
Nora Torok et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Multiple Sclerosis and Serotonin: Potential Therapeutic Applications
Aleyda M. San Hernandez et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Traumatic Injury Leads to Inflammation and Altered Tryptophan Metabolism in the Juvenile Rabbit Brain
Zhi Zhang et al.
JOURNAL OF NEUROTRAUMA (2019)
Amino acid metabolism as drug target in autoimmune diseases
Giada Mondanelli et al.
AUTOIMMUNITY REVIEWS (2019)
Melatonin receptor activation provides cerebral protection after traumatic brain injury by mitigating oxidative stress and inflammation via the Nrf2 signaling pathway
Junmin Wang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Michael Platten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Exchange-mode glutamine transport across CNS cell membranes
Jan Albrecht et al.
NEUROPHARMACOLOGY (2019)
Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage
Huimin Zhu et al.
PROGRESS IN NEUROBIOLOGY (2019)
Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder
Yanling Zhou et al.
PSYCHONEUROENDOCRINOLOGY (2019)
The Yin' and the Yang' of the kynurenine pathway: excitotoxicity and neuroprotection imbalance in stress-induced disorders
Pascal Barone
BEHAVIOURAL PHARMACOLOGY (2019)
PEG-Poly(1-Methyl-l-Tryptophan)-Based Polymeric Micelles as Enzymatically Activated Inhibitors of Indoleamine 2,3-Dioxygenase
George Lo Huang et al.
NANOMATERIALS (2019)
Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial
Melissa Cambron et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Pineal gland and schizophrenia: A systematic review and meta-analysis
Marco Aurelio Vinhosa Bastos et al.
PSYCHONEUROENDOCRINOLOGY (2019)
Management of oxidative stress and other pathologies in Alzheimer's disease
Miriama Simunkova et al.
ARCHIVES OF TOXICOLOGY (2019)
Serotonergic mechanisms in spinal cord injury
Florence Evelyne Perrin et al.
EXPERIMENTAL NEUROLOGY (2019)
Myelin status and oligodendrocyte lineage cells over time after spinal cord injury: What do we know and what still needs to be unwrapped?
Nicole Pukos et al.
GLIA (2019)
5-HT1A receptor, 5-HT2A receptor and serotonin transporter binding in the human auditory cortex in depression
Louisa J. Steinberg et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2019)
Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis
Vanessa X. Tan et al.
FRONTIERS IN NEUROSCIENCE (2019)
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells
Marco Gargaro et al.
FRONTIERS IN IMMUNOLOGY (2019)
Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease
Pratishtha Chatterjee et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Kynurenine metabolism and inflammation-induced depressed mood: A human experimental study
Jennifer L. Kruse et al.
PSYCHONEUROENDOCRINOLOGY (2019)
Systemic and central nervous system metabolic alterations in Alzheimer's disease
Vera van der Velpen et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington's disease
Fanni A. Boros et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Neuroprotective effect of naringenin against MPTP-induced oxidative stress
Mani Sugumar et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2019)
Grey and white matter structure associates with the activation of the tryptophan to kynurenine pathway in bipolar disorder
Sara Poletti et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Therapeutic role of melatonin in migraine prophylaxis A systematic review
Rujin Long et al.
MEDICINE (2019)
Serotonin and Glutamate Interactions in Preclinical Schizophrenia Models
Urjita H. Shah et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Phytochemical treatments target kynurenine pathway induced oxidative stress
K. Parasram
REDOX REPORT (2018)
Circadian modulation of neuroplasticity by melatonin: a target in the treatment of depression
Marcela Valdes-Tovar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
IDO1 in cancer: a Gemini of immune checkpoints
Lijie Zhai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Isehemic Stroke and Kynurenines: Medicinal Chemistry Aspects
Peter Hertelendy et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Biochemistry and structural studies of kynurenine 3-monooxygenase reveal allosteric inhibition by Ro 61-8048
Jingjing Gao et al.
FASEB JOURNAL (2018)
Multi-Faceted Role of Melatonin in Neuroprotection and Amelioration of Tau Aggregates in Alzheimer's Disease
Abhishek Ankur Balmik et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines
Denes Zadori et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
The neuroprotective role of melatonin in neurological disorders
B. S. Alghamdi
JOURNAL OF NEUROSCIENCE RESEARCH (2018)
Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson's Disease
Kuo-Hsuan Chang et al.
MOLECULAR NEUROBIOLOGY (2018)
Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia
Joshua Chiappelli et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Antinociceptive Effects of the Antidepressant Phenelzine are Mediated by Context-Dependent Inhibition of Neuronal Responses in the Dorsal Horn
Liam E. Potter et al.
NEUROSCIENCE (2018)
Relevance of Alternative Routes of Kynurenic Acid Production in the Brain
L. A. Ramos-Chavez et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Improvement of kynurenine aminotransferase-II inhibitors guided by mimicking sulfate esters
Gayan S. Jayawickrama et al.
PLOS ONE (2018)
Circadian rhythm in bipolar disorder: A review of the literature
Yoshikazu Takaesu
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2018)
Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes
Kelly Doolin et al.
PSYCHONEUROENDOCRINOLOGY (2018)
Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-beta load: A pilot study
Pratishtha Chatterjee et al.
SCIENTIFIC REPORTS (2018)
Pharmacological Inhibition of Indoleamine 2,3-Dioxygenase-2 and Kynurenine 3-Monooxygenase, Enzymes of the Kynurenine Pathway, Significantly Diminishes Neuropathic Pain in a Rat Model
Ewelina Rojewska et al.
FRONTIERS IN PHARMACOLOGY (2018)
Rollercoaster ride of kynurenines: steering the wheel towards neuroprotection in Alzheimer's disease
Radhika Sharma et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Melatonin and inflammation-Story of a double-edged blade
Ruediger Hardeland
JOURNAL OF PINEAL RESEARCH (2018)
Melatonin for the treatment of spinal cord injury
Yan Zhang et al.
NEURAL REGENERATION RESEARCH (2018)
Endoplasmic reticulum stress leads to accumulation of wild-type SOD1 aggregates associated with sporadic amyotrophic lateral sclerosis
Danilo B. Medinas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Serotonin Selective Reuptake Inhibitors (SSRIs) and Stroke
F. Chollet et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2018)
Anxiety Disorders: Sex Differences in Serotonin and Tryptophan Metabolism
Tanya Songtachalert et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
Inhibiting the kynurenine pathway in spinal cord injury: multiple therapeutic potentials?
Kelly R. Jacobs et al.
NEURAL REGENERATION RESEARCH (2018)
Aryl hydrocarbon receptor signaling modifies Toll-like receptor-regulated responses in human dendritic cells
Sarah Kado et al.
ARCHIVES OF TOXICOLOGY (2017)
A comparative assessment of two kynurenic acid analogs in the formalin model of trigeminal activation: a behavioral, immunohistochemical and pharmacokinetic study
Gabor Veres et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Regulating the balance between the kynurenine and serotonin pathways of tryptophan metabolism
Yang Li et al.
FEBS JOURNAL (2017)
Modulating 5-HT4 and 5-HT6 receptors in Alzheimer's disease treatment
Julien Lalut et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors
Francesco Fazio et al.
NEUROPHARMACOLOGY (2017)
Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis
Jong-Min Lee et al.
NEUROPHARMACOLOGY (2017)
The kynurenine pathway in schizophrenia and bipolar disorder
Sophie Erhardt et al.
NEUROPHARMACOLOGY (2017)
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases
Michael D. Lovelace et al.
NEUROPHARMACOLOGY (2017)
3-Hydroxykynurenine and 3-Hydroxyanthranilic Acid Enhance the Toxicity Induced by Copper in Rat Astrocyte Culture
Daniela Ramirez-Ortega et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Crosstalk between Tryptophan Metabolism and Cardiovascular Disease, Mechanisms, and Therapeutic Implications
Gang Liu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease
Chai K. Lim et al.
PROGRESS IN NEUROBIOLOGY (2017)
Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health
Igor Cervenka et al.
SCIENCE (2017)
Serum kynurenic acid is reduced in affective psychosis
B. E. Wurfel et al.
TRANSLATIONAL PSYCHIATRY (2017)
Neuroprotective action of N-acetyl serotonin in oxidative stress-induced apoptosis through the activation of both TrkB/CREB/BDNF pathway and Akt/Nrf2/Antioxidant enzyme in neuronal cells
Jae-Myung Yoo et al.
REDOX BIOLOGY (2017)
Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder
Armin Birner et al.
PLOS ONE (2017)
Biomarker Research in Parkinson's Disease Using Metabolite Profiling
Jesper F. Havelund et al.
METABOLITES (2017)
Huntington's Disease-Update on Treatments
Kara J. Wyant et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2017)
Identification of novel biomarkers for Parkinson's disease by metabolomic technologies
Taku Hatano et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder
C. M. Sellgren et al.
MOLECULAR PSYCHIATRY (2016)
Development of a RapidFire mass spectrometry assay and a fluorescence assay for the discovery of kynurenine aminotransferase II inhibitors to treat central nervous system disorders
Hao Lu et al.
ANALYTICAL BIOCHEMISTRY (2016)
L-DOPA-induced hyperhomocysteinemia in Parkinson's disease: Elephant in the room
Rajib Paul et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)
Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: Both effects are reversed by inhibition of indoleamine 2,3-dioxygenase
Rene Fuertig et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms
Shahin Aeinehband et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression
Kymberly D. Young et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Drug treatments in Alzheimer's disease
Robert Briggs et al.
CLINICAL MEDICINE (2016)
Mood, food, and cognition: role of tryptophan and serotonin
Barbara Strasser et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2016)
Bipolar Disorder: The Role of the Kynurenine and Melatonergic Pathways
George Anderson et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia
Maria Isabel Cuartero et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease
Vahri Beaumont et al.
EXPERIMENTAL NEUROLOGY (2016)
Melatonin as an antioxidant: under promises but over delivers
Russel J. Reiter et al.
JOURNAL OF PINEAL RESEARCH (2016)
TDO as a therapeutic target in brain diseases
Cheng-Peng Yu et al.
METABOLIC BRAIN DISEASE (2016)
Study of the Activity and Possible Mechanism of Action of a Reversible Inhibitor of Recombinant Human KAT-2: A Promising Lead in Neurodegenerative and Cognitive Disorders
Alireza Nematollahi et al.
MOLECULES (2016)
An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation
L. Brundin et al.
TRANSLATIONAL PSYCHIATRY (2016)
Current evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis
Michael D. Lovelace et al.
FRONTIERS IN IMMUNOLOGY (2016)
Emerging therapeutic roles for NAD+ metabolism in mitochondrial and age-related disorders
Sarika Srivastava
CLINICAL AND TRANSLATIONAL MEDICINE (2016)
Melatonin Redox Activity. Its Potential Clinical Applications in Neurodegenerative Disorders
Elzbieta Miller et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations
Zsuzsanna Bohar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Development of a Series of Aryl Pyrimidine Kynurenine Monooxygenase Inhibitors as Potential Therapeutic Agents for the Treatment of Huntington's Disease
Leticia M. Toledo-Sherman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Targeting inflammation to influence mood following spinal cord injury: a randomized clinical trial
David J. Allison et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans
Edwin B. Yan et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain
Baptiste Lacoste et al.
JOURNAL OF PINEAL RESEARCH (2015)
Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies
Gislaine Z. Reus et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
Review of Amyotrophic Lateral Sclerosis, Parkinson's and Alzheimer's diseases helps further define pathology of the novel paradigm for Alzheimer's with heavy metals as primary disease cause
Franco Cavaleri
MEDICAL HYPOTHESES (2015)
Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response
Paul W. Andrews et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation
Marie Favennec et al.
OBESITY (2015)
Central nervous system-specific alterations in the tryptophan metabolism in the 3-nitropropionic acid model of Huntington's disease
Gabor Veres et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
NAD+ in aging, metabolism, and neurodegeneration
Eric Verdin
SCIENCE (2015)
The kynurenine pathway and neurodegenerative disease
Daniel C. Maddison et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia
Francesco Fazio et al.
SCIENTIFIC REPORTS (2015)
Rational modulation of the innate immune system for neuroprotection in ischemic stroke
Diana Amantea et al.
FRONTIERS IN NEUROSCIENCE (2015)
Kynurenine 3-monooxygenase: an influential mediator of neuropathology
Jennifer M. Parrott et al.
FRONTIERS IN PSYCHIATRY (2015)
The IDO Inhibitor Coptisine Ameliorates Cognitive Impairment in a Mouse Model of Alzheimer's Disease
Dan Yu et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Serum indoleamine 2,3-dioxygenase and kynurenine aminotransferase enzyme activity in patients with ischemic stroke
Mo Ximing et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2014)
Identification of Cinnabarinic Acid as a Novel Endogenous Aryl Hydrocarbon Receptor Ligand That Drives IL-22 Production
Margaret M. Lowe et al.
PLOS ONE (2014)
Proliferation in the Alzheimer Hippocampus Is due to Microglia, Not Astroglia, and Occurs at Sites of Amyloid Deposition
Michael W. Marlatt et al.
NEURAL PLASTICITY (2014)
Serotonin - Kynurenine Hypothesis of Depression: Historical Overview and Recent Developments
Gregory Oxenkrug
CURRENT DRUG TARGETS (2013)
On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK
Annia Galano et al.
JOURNAL OF PINEAL RESEARCH (2013)
3-Hydroxykynurenine and Other Parkinson's Disease Biomarkers Discovered by Metabolomic Analysis
Peter A. LeWitt et al.
MOVEMENT DISORDERS (2013)
Kynurenines in the CNS: recent advances and new questions
Laszlo Vecsei et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Targeting Kynurenine 3-Monooxygenase (KMO): Implications for Therapy in Huntingtons Disease
Mathuravani A. Thevandavakkam et al.
CNS & Neurological Disorders-Drug Targets (2012)
Quinolinic acid, the inescapable neurotoxin
Gilles J. Guillemin
FEBS JOURNAL (2012)
The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications
Judit Fuevesi et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
The kynurenine pathway in neurodegenerative diseases: Mechanistic and therapeutic considerations
Lin Tan et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Association of a polymorphism in the indoleamine-2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C
A. K. Smith et al.
MOLECULAR PSYCHIATRY (2012)
Kynurenines in the mammalian brain: when physiology meets pathology
Robert Schwarcz et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Picolinic Acid in Patients with Chronic Hepatitis C Infection: A Preliminary Report
Jolanta Zuwala-Jagiello et al.
MEDIATORS OF INFLAMMATION (2012)
Influence of Tryptophan Contained in 1-Methyl-Tryptophan on Antimicrobial and Immunoregulatory Functions of Indoleamine 2,3-Dioxygenase
Silvia K. Schmidt et al.
PLOS ONE (2012)
Age-Associated Changes In Oxidative Stress and NAD+ Metabolism In Human Tissue
Hassina Massudi et al.
PLOS ONE (2012)
Xanthurenic Acid Binds to Neuronal G-Protein-Coupled Receptors That Secondarily Activate Cationic Channels in the Cell Line NCB-20
Omar Taleb et al.
PLOS ONE (2012)
Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
Daniel C. Javitt et al.
SCHIZOPHRENIA BULLETIN (2012)
Decreased Expression of Transient Receptor Potential Channels in Cerebral Vascular Tissue from Patients After Hypertensive Intracerebral Hemorrhage
Florian Thilo et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2011)
Different inhibitory effects of kynurenic acid and a novel kynurenic acid analogue on tumour necrosis factor-α (TNF-α) production by mononuclear cells, HMGB1 production by monocytes and HNP1-3 secretion by neutrophils
Zoltan Tiszlavicz et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)
Fluctuations in Endogenous Kynurenic Acid Control Hippocampal Glutamate and Memory
Ana Pocivavsek et al.
NEUROPSYCHOPHARMACOLOGY (2011)
The new '5-HT' hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
M. Maes et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Expression of functional GPR35 in human iNKT cells
Silvia Fallarini et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease
Caroline M. Forrest et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Indoleamine 2,3-dioxygenase and 3-hydroxy-kynurenine modifications are found in the neuropathology of Alzheimer's disease
David J. Bonda et al.
REDOX REPORT (2010)
Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease
Robert Schwarcz et al.
PROGRESS IN NEUROBIOLOGY (2010)
Kynurenic Acid Is a Potent Endogenous Aryl Hydrocarbon Receptor Ligand that Synergistically Induces Interleukin-6 in the Presence of Inflammatory Signaling
Brett C. DiNatale et al.
TOXICOLOGICAL SCIENCES (2010)
On the Biological Importance of the 3-hydroxyanthranilic Acid: Anthranilic Acid Ratio
L. Gail Darlington et al.
INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH (2010)
Mechanism for Quinolinic Acid Cytotoxicity in Human Astrocytes and Neurons
Nady Braidy et al.
NEUROTOXICITY RESEARCH (2009)
Melatonin, Circadian Rhythms, and the Clock Genes in Bipolar Disorder
Sara Dallaspezia et al.
CURRENT PSYCHIATRY REPORTS (2009)
Characterization of the kynurenine pathway in human neurons
Gilles J. Guillemin et al.
JOURNAL OF NEUROSCIENCE (2007)
Mechanisms of Copper Ion Mediated Huntington's Disease Progression
Jonathan H. Fox et al.
PLOS ONE (2007)
Tryptophan metabolism and oxidative stress in patients with Huntington's disease
N Stoy et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis
J Ilzecka et al.
ACTA NEUROLOGICA SCANDINAVICA (2003)
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia
S Erhardt et al.
NEUROSCIENCE LETTERS (2001)
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
GJ Guillemin et al.
JOURNAL OF NEUROCHEMISTRY (2001)
分享论文
